Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
Abroad (travel likely)RecruitingPHASE1
Conditions
Unresectable Pancreatic Cancer · Advanced Pancreatic Cancer · Lymph Node Metastases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Suxia Luo)Contact: Principal Investigator (Suxia Luo)Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Duanmin Hu)Contact: Principal Investigator (Duanmin Hu)Shanghai Changhai Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Zhaoshen Li)Contact: Study coordinator (Yiqi Du)Contact: Principal Investigator (Zhaoshen Li)Contact: Principal Investigator (Yiqi Du)Shanghai General Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Qi Li)Contact: Study coordinator (Xueying Ding)Contact: Principal Investigator (Qi Li)Contact: Principal Investigator (Xueying Ding)Chongqing University Cancer Hospital, Chongqing, China
Contact: Study coordinator (Weiqing Chen)Contact: Principal Investigator (Weiqing Chen)Tianjin Medical University General Hospital, Tianjin, China
Contact: Study coordinator (Bangmao Wang)Contact: Principal Investigator (Bangmao Wang)
Study leads
Zhaoshen Li
Principal Investigator
Changhai Hospital